A study on NSCLC patients’ serum exosomes demonstrated that high expression level of exosomal programmed cell-death ligand 1 (PD-L1) was closely associated with cancer patients’ advanced tumor stage, larger tumor size and positive metastasis (Li et al., 2019). The gene discussed is CD274; the disease is non-small cell lung carcinoma.